Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the relationship between achieving symptomatic
remission status by means of the 8 items of Positive and Negative Syndrome Scale (PANSS), and
personal and social functioning by means of the Personal and Social Performance (PSP) scale
in participants treated with flexibly dosed paliperidone ER.